Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Pathogenic T helper type 17 cells contribute to type 1 diabetes independently of interleukin-22.

Bellemore SM, Nikoopour E, Krougly O, Lee-Chan E, Fouser LA, Singh B.

Clin Exp Immunol. 2016 Mar;183(3):380-8. doi: 10.1111/cei.12735. Epub 2015 Dec 3.

2.

Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus.

Morrison PJ, Ballantyne SJ, Macdonald SJ, Moore JW, Jenkins D, Wright JF, Fouser LA, Kullberg MC.

Am J Pathol. 2015 Dec;185(12):3290-303. doi: 10.1016/j.ajpath.2015.08.015. Epub 2015 Oct 14.

3.

Epithelial-intrinsic IKK╬▒ expression regulates group 3 innate lymphoid cell responses and antibacterial immunity.

Giacomin PR, Moy RH, Noti M, Osborne LC, Siracusa MC, Alenghat T, Liu B, McCorkell KA, Troy AE, Rak GD, Hu Y, May MJ, Ma HL, Fouser LA, Sonnenberg GF, Artis D.

J Exp Med. 2015 Sep 21;212(10):1513-28. doi: 10.1084/jem.20141831. Epub 2015 Sep 14.

4.

Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells.

Bishop JL, Roberts ME, Beer JL, Huang M, Chehal MK, Fan X, Fouser LA, Ma HL, Bacani JT, Harder KW.

Mucosal Immunol. 2014 Mar;7(2):405-16. doi: 10.1038/mi.2013.60. Epub 2013 Sep 18.

PMID:
24045577
5.

Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation.

Morrison PJ, Bending D, Fouser LA, Wright JF, Stockinger B, Cooke A, Kullberg MC.

Mucosal Immunol. 2013 Nov;6(6):1143-56. doi: 10.1038/mi.2013.11. Epub 2013 Mar 6.

PMID:
23462910
6.

The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes.

Hill T, Krougly O, Nikoopour E, Bellemore S, Lee-Chan E, Fouser LA, Hill DJ, Singh B.

Cell Regen (Lond). 2013 Apr 4;2(1):2. doi: 10.1186/2045-9769-2-2. eCollection 2013.

7.

The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Weaver CT, Elson CO, Fouser LA, Kolls JK.

Annu Rev Pathol. 2013 Jan 24;8:477-512. doi: 10.1146/annurev-pathol-011110-130318. Epub 2012 Nov 15. Review.

8.

Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, Singer NV, West ML, Jenq RR, Holland AM, Kappel LW, Ghosh A, Tsai JJ, Rao UK, Yim NL, Smith OM, Velardi E, Hawryluk EB, Murphy GF, Liu C, Fouser LA, Kolesnick R, Blazar BR, van den Brink MR.

Immunity. 2012 Aug 24;37(2):339-50. doi: 10.1016/j.immuni.2012.05.028.

9.

Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria.

Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang KM, Artis D.

Science. 2012 Jun 8;336(6086):1321-5. doi: 10.1126/science.1222551. Epub 2012 Jun 6.

10.

IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.

Van Belle AB, de Heusch M, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K, Fouser LA, Renauld JC, Dumoutier L.

J Immunol. 2012 Jan 1;188(1):462-9. doi: 10.4049/jimmunol.1102224. Epub 2011 Nov 30.

11.

Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.

Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, Medley QG.

J Invest Dermatol. 2011 Dec;131(12):2428-37. doi: 10.1038/jid.2011.234. Epub 2011 Sep 1.

12.

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Sonnenberg GF, Fouser LA, Artis D.

Nat Immunol. 2011 May;12(5):383-90. doi: 10.1038/ni.2025. Review.

PMID:
21502992
13.

CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut.

Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D.

Immunity. 2011 Jan 28;34(1):122-34. doi: 10.1016/j.immuni.2010.12.009. Epub 2010 Dec 30.

14.

Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces.

Sonnenberg GF, Fouser LA, Artis D.

Adv Immunol. 2010;107:1-29. doi: 10.1016/B978-0-12-381300-8.00001-0. Review.

PMID:
21034969
15.

IL-22 induces an acute-phase response.

Liang SC, Nickerson-Nutter C, Pittman DD, Carrier Y, Goodwin DG, Shields KM, Lambert AJ, Schelling SH, Medley QG, Ma HL, Collins M, Dunussi-Joannopoulos K, Fouser LA.

J Immunol. 2010 Nov 1;185(9):5531-8. doi: 10.4049/jimmunol.0904091. Epub 2010 Sep 24.

16.

Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A.

Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D.

J Exp Med. 2010 Jun 7;207(6):1293-305. doi: 10.1084/jem.20092054. Epub 2010 May 24.

17.

Th17 cytokines and their emerging roles in inflammation and autoimmunity.

Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M.

Immunol Rev. 2008 Dec;226:87-102. doi: 10.1111/j.1600-065X.2008.00712.x. Review.

PMID:
19161418
18.

IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.

Wu PW, Li J, Kodangattil SR, Luxenberg DP, Bennett F, Martino M, Collins M, Dunussi-Joannopoulos K, Gill DS, Wolfman NM, Fouser LA.

J Mol Biol. 2008 Oct 24;382(5):1168-83. doi: 10.1016/j.jmb.2008.07.046. Epub 2008 Jul 25.

PMID:
18675824
19.

IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S, Senices M, Gill D, Dunussi-Joannopoulos K, Collins M, Nickerson-Nutter C, Fouser LA, Young DA.

J Clin Invest. 2008 Feb;118(2):597-607. doi: 10.1172/JCI33263.

20.

An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment.

Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, Collins M, Goldman SJ, Dunussi-Joannopoulos K, Williams CM, Wright JF, Fouser LA.

J Immunol. 2007 Dec 1;179(11):7791-9.

21.

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.

Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA.

J Exp Med. 2006 Oct 2;203(10):2271-9. Epub 2006 Sep 18.

22.

Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.

Li J, Tomkinson KN, Tan XY, Wu P, Yan G, Spaulding V, Deng B, Annis-Freeman B, Heveron K, Zollner R, De Zutter G, Wright JF, Crawford TK, Liu W, Jacobs KA, Wolfman NM, Ling V, Pittman DD, Veldman GM, Fouser LA.

Int Immunopharmacol. 2004 May;4(5):693-708. Review.

PMID:
15120653
23.

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.

Carter L, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, Collins M, Honjo T, Freeman GJ, Carreno BM.

Eur J Immunol. 2002 Mar;32(3):634-43.

24.

Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor.

Ling V, Wu PW, Finnerty HF, Bean KM, Spaulding V, Fouser LA, Leonard JP, Hunter SE, Zollner R, Thomas JL, Miyashiro JS, Jacobs KA, Collins M.

J Immunol. 2000 Feb 15;164(4):1653-7.

25.

P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells.

Vachino G, Chang XJ, Veldman GM, Kumar R, Sako D, Fouser LA, Berndt MC, Cumming DA.

J Biol Chem. 1995 Sep 15;270(37):21966-74.

26.

High level expression on a chimeric anti-ganglioside GD2 antibody: genomic kappa sequences improve expression in COS and CHO cells.

Fouser LA, Swanberg SL, Lin BY, Benedict M, Kelleher K, Cumming DA, Riedel GE.

Biotechnology (N Y). 1992 Oct;10(10):1121-7.

PMID:
1382457
27.

Supplemental Content

Loading ...
Support Center